NRP1 forms complexes with Flk-1/KDR (VEGFR2) to enhance the binding of VEGF165 to VEGFRs, and promotes VEGF165-mediated tumor angiogenesis, cell migration and tumorigenicity (29,30). The gene discussed is KDR; the disease is neoplasm.